Parity-priced medications are a hidden pricing tactic used by pharmaceutical manufacturers to drive additional revenue – at the expense of unsuspecting payors.
The Risk for Plans: Providers may prescribe the lower-strength version containing more units instead of the higher-strength version containing fewer units. These missed dose optimization opportunities can result in doubled or tripled plan costs. A claims analysis can be conducted by your pharmacy benefits provider to identify if parity-priced drugs are being covered by your plan.